Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
BMC Microbiology|January 23, 2021
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCRTania Desmet, Peter De Paepe, Jerina Boelens, et al.
Vaccines|January 8, 2025
Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older AdultsBart Jacobs, Isabel Leroux-Roels, Jacques Bruhwyler, et al.
The Journal of Infectious Diseases|October 24, 2024
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 StudyIsabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2026
Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: a randomized, non-inferiority trialIsabel Leroux-Roels, Muriel Lins, Ronald Surowitz, et al.
Vaccines|February 26, 2026
Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 StudyIsabel Leroux-Roels, Tracey A Day, Sofie Deleu, et al.
Vaccines|September 28, 2024
Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 StudyValentino D'Onofrio, Sharon Porrez, Bart Jacobs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 12, 2026
A standardized workflow for typing S. marcescens outbreaks using FT-IR spectroscopyIoannis Passaris, Sam Van Goethem, Florence Crombé, et al.
Expert Review of Vaccines|June 8, 2026
From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virusCláudia Vicente, Filipe Froes, Pier Luigi Lopalco, et al.
Frontiers in Immunology|August 14, 2025
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cellsValentino D'Onofrio, Ana Carolina Santana, Marthe Pauwels, et al.
Frontiers in Immunology|April 25, 2022
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza VaccineIsabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, et al.
Pageof 8